New York City-based Sols announced in late February that it has secured $11.1 million in a Series B funding round to boost its consumer product pipeline.
The digital insole manufacturer will use the infusion of capital to prepare for its second-quarter launch of direct-to-consumer 3D-printed insoles, according to a company release.
Patients will be able to use a smartphone app to scan their feet, upload scans, and place insole orders online. Sols is positioning the insoles as a premium alternative to existing over-the-counter products. Since its July 2013 launch, the company has raised $19.3 million and established a network of 344 practitioners who provide medical- grade insoles.